These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 25130853

  • 1. [Role of ASXL1 mutation in myeloid malignancies].
    Sheng MY, Zhou Y, Xu MJ, Yang FC.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1183-7. PubMed ID: 25130853
    [Abstract] [Full Text] [Related]

  • 2. Epigenetic regulation by ASXL1 in myeloid malignancies.
    Yang FC, Agosto-Peña J.
    Int J Hematol; 2023 Jun; 117(6):791-806. PubMed ID: 37062051
    [Abstract] [Full Text] [Related]

  • 3. Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases.
    Gelsi-Boyer V, Brecqueville M, Devillier R, Murati A, Mozziconacci MJ, Birnbaum D.
    J Hematol Oncol; 2012 Mar 21; 5():12. PubMed ID: 22436456
    [Abstract] [Full Text] [Related]

  • 4. Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms.
    Asada S, Kitamura T.
    Int J Hematol; 2019 Aug 21; 110(2):179-186. PubMed ID: 30515738
    [Abstract] [Full Text] [Related]

  • 5. Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
    Gelsi-Boyer V, Trouplin V, Adélaïde J, Bonansea J, Cervera N, Carbuccia N, Lagarde A, Prebet T, Nezri M, Sainty D, Olschwang S, Xerri L, Chaffanet M, Mozziconacci MJ, Vey N, Birnbaum D.
    Br J Haematol; 2009 Jun 21; 145(6):788-800. PubMed ID: 19388938
    [Abstract] [Full Text] [Related]

  • 6. [Pathophysiology of hematological malignancies associated with ASXL1 mutations].
    Fujino T.
    Rinsho Ketsueki; 2022 Jun 21; 63(6):561-572. PubMed ID: 35831189
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes.
    Thol F, Friesen I, Damm F, Yun H, Weissinger EM, Krauter J, Wagner K, Chaturvedi A, Sharma A, Wichmann M, Göhring G, Schumann C, Bug G, Ottmann O, Hofmann WK, Schlegelberger B, Heuser M, Ganser A.
    J Clin Oncol; 2011 Jun 20; 29(18):2499-506. PubMed ID: 21576631
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study.
    Fei F, Jariwala A, Pullarkat S, Loo E, Liu Y, Tizro P, Ali H, Otoukesh S, Amanam I, Artz A, Ally F, Telatar M, Nakamura R, Marcucci G, Afkhami M.
    Int J Mol Sci; 2024 Sep 23; 25(18):. PubMed ID: 39337700
    [Abstract] [Full Text] [Related]

  • 16. Mutations in chronic myelomonocytic leukemia and their prognostic relevance.
    Jian J, Qiao Y, Li Y, Guo Y, Ma H, Liu B.
    Clin Transl Oncol; 2021 Sep 23; 23(9):1731-1742. PubMed ID: 33861431
    [Abstract] [Full Text] [Related]

  • 17. Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemia.
    Cervera N, Itzykson R, Coppin E, Prebet T, Murati A, Legall S, Vey N, Solary E, Birnbaum D, Gelsi-Boyer V.
    Am J Hematol; 2014 Jun 23; 89(6):604-9. PubMed ID: 24595958
    [Abstract] [Full Text] [Related]

  • 18. [Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment].
    Harada Y, Harada H.
    Rinsho Ketsueki; 2016 Feb 23; 57(2):147-55. PubMed ID: 26935632
    [Abstract] [Full Text] [Related]

  • 19. ASXL1 mutations in myeloid neoplasms: pathogenetic considerations, impact on clinical outcomes and survival.
    Alvarez Argote J, Dasanu CA.
    Curr Med Res Opin; 2018 May 23; 34(5):757-763. PubMed ID: 28027687
    [Abstract] [Full Text] [Related]

  • 20. The role of ASXL1 in hematopoiesis and myeloid malignancies.
    Asada S, Fujino T, Goyama S, Kitamura T.
    Cell Mol Life Sci; 2019 Jul 23; 76(13):2511-2523. PubMed ID: 30927018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.